Pharma research outsourcing faces speed bumps

Venkat Jasti, vice-chairman and managing director of Suven Life Sciences, is an optimist on new drug discovery. But Suven's last major new drug discovery collaboration deal was more than two years......

Pharma: Formulations escape excise duty hike

The excise duty was increased on bulk drugs and intermediates from 8% to 10%, but fortunately the excise duty on formulations remains at 4% Budget provisions The excise duty on drugs......

A pill for your investment woes

During uncertain times investors flock to pharmaceutical stocks. Here's how to evaluate them. Pharmaceutical companies are seen as defensive stocks. During uncertain markets, there is a flight......

Suven ties up with Eli Lilly

Suven Lifesciences and Eli Lilly have got into an alliance for drug discovery. Eli and Suven will collaborate for pre-clinical development of the CNS molecule, reports CNBC-TV18. As a part of this......